AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1,269 Cr | ₹120 Cr | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr |
What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-1,269 Cr |
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹800 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹-2,969 Cr |
How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,269 Cr | Negative | |
| Mar2025 | ₹120 Cr | -85.04 | |
| Mar2024 | ₹800 Cr | -55.89 | |
| Mar2023 | ₹1,814 Cr | Positive | |
| Mar2022 | ₹-2,969 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹95,516.4 Cr | -0.7% | 0.6% | 48.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.2% | -4.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -3.1% | -1.6% | 47.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -1.2% | -5% | 29.4% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 2.3% | -2% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 2.2% | 6.2% | -2.5% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -0.7% |
0.6% |
48.5% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses